SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4p2b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CD2_A_FOLA307_0 (DIHYDROFOLATE REDUCTASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	ILE A 42 ALA A 68 PRO A 47 PHE A 79 ILE A 238	None	0.87A	1cd2A-4p2bA: undetectable	1cd2A-4p2bA: 16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P7R_A_NCTA440_1 (CYTOCHROME P450-CAM)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	THR A 367 VAL A 433 VAL A 364 ILE A 366	None	0.98A	1p7rA-4p2bA: undetectable	1p7rA-4p2bA: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.38A	1v54N-4p2bA: undetectable 1v54P-4p2bA: undetectable	1v54N-4p2bA: 20.13 1v54P-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.40A	1v55A-4p2bA: undetectable 1v55C-4p2bA: undetectable	1v55A-4p2bA: 20.13 1v55C-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CD2_A_FOLA307_0 (DIHYDROFOLATE REDUCTASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	ILE A 42 ALA A 68 PRO A 47 PHE A 79 ILE A 238	None	0.85A	2cd2A-4p2bA: undetectable	2cd2A-4p2bA: 16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.38A	2dyrN-4p2bA: undetectable 2dyrP-4p2bA: undetectable	2dyrN-4p2bA: 20.13 2dyrP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.41A	2dysA-4p2bA: undetectable 2dysC-4p2bA: undetectable	2dysA-4p2bA: 20.13 2dysC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EGV_A_SAMA1300_0 (UPF0088 PROTEIN AQ_165)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	LEU A 309 VAL A 314 GLY A 313 LEU A 303 THR A 572	None	0.99A	2egvA-4p2bA: 2.2	2egvA-4p2bA: 18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.41A	2eijA-4p2bA: undetectable 2eijC-4p2bA: undetectable	2eijA-4p2bA: 20.13 2eijC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.39A	2eijN-4p2bA: undetectable 2eijP-4p2bA: undetectable	2eijN-4p2bA: 20.13 2eijP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.40A	2eikA-4p2bA: undetectable 2eikC-4p2bA: undetectable	2eikA-4p2bA: 20.13 2eikC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.36A	2eikN-4p2bA: undetectable 2eikP-4p2bA: undetectable	2eikN-4p2bA: 20.13 2eikP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.42A	2eilA-4p2bA: undetectable 2eilC-4p2bA: undetectable	2eilA-4p2bA: 20.13 2eilC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.39A	2eilN-4p2bA: undetectable 2eilP-4p2bA: undetectable	2eilN-4p2bA: 20.13 2eilP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.36A	2eimA-4p2bA: undetectable 2eimC-4p2bA: undetectable	2eimA-4p2bA: 20.13 2eimC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.45A	2eimN-4p2bA: undetectable 2eimP-4p2bA: undetectable	2eimN-4p2bA: 20.13 2eimP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.42A	2einA-4p2bA: undetectable 2einC-4p2bA: undetectable	2einA-4p2bA: 20.13 2einC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.38A	2einN-4p2bA: undetectable 2einP-4p2bA: undetectable	2einN-4p2bA: 20.13 2einP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIP_A_MTXA605_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	VAL A 339 LEU A 319 PHE A 322 THR A 279 LEU A 274	None	1.01A	2oipA-4p2bA: undetectable	2oipA-4p2bA: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIP_C_MTXC613_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	VAL A 339 LEU A 319 PHE A 322 THR A 279 LEU A 274	None	1.04A	2oipC-4p2bA: undetectable	2oipC-4p2bA: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.41A	2zxwA-4p2bA: undetectable 2zxwC-4p2bA: undetectable	2zxwA-4p2bA: 20.13 2zxwC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.38A	2zxwN-4p2bA: undetectable 2zxwP-4p2bA: undetectable	2zxwN-4p2bA: 20.13 2zxwP-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.43A	3abkA-4p2bA: undetectable 3abkC-4p2bA: undetectable	3abkA-4p2bA: 20.13 3abkC-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.41A	3ag1A-4p2bA: undetectable 3ag1C-4p2bA: undetectable	3ag1A-4p2bA: 20.13 3ag1C-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.40A	3ag2A-4p2bA: undetectable 3ag2C-4p2bA: undetectable	3ag2A-4p2bA: 20.13 3ag2C-4p2bA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FL9_D_TOPD200_1 (DIHYDROFOLATE REDUCTASE (DHFR))	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 9	ALA A 58 LEU A 306 ILE A 95 LEU A 77 PHE A 45	None	1.45A	3fl9D-4p2bA: undetectable	3fl9D-4p2bA: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_B_SALB3004_1 (TRANSCRIPTIONAL REGULATOR TCAR)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 5	ILE A 95 PHE A 79 ASP A 80 GLU A 48	None	0.98A	3kp6A-4p2bA: undetectable 3kp6B-4p2bA: undetectable	3kp6A-4p2bA: 14.34 3kp6B-4p2bA: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGP_A_017A200_2 (FIV PROTEASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 10	LEU A 309 ALA A 58 GLY A 103 VAL A 314 LEU A 319	None	1.31A	3ogpB-4p2bA: undetectable	3ogpB-4p2bA: 12.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9T_A_BEZA264_0 (ECHA1_1)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 8	ALA A 481 ILE A 483 ALA A 527 ALA A 528	None	0.57A	3r9tA-4p2bA: undetectable	3r9tA-4p2bA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_C_ACHC323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 8	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.77A	3rqwC-4p2bA: undetectable 3rqwD-4p2bA: undetectable	3rqwC-4p2bA: 18.26 3rqwD-4p2bA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_I_ACHI323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 8	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.75A	3rqwI-4p2bA: undetectable 3rqwJ-4p2bA: undetectable	3rqwI-4p2bA: 18.26 3rqwJ-4p2bA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_J_ACHJ323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 8	GLU A 374 TYR A 428 PHE A 394 ASN A 368	None	0.74A	3rqwF-4p2bA: undetectable 3rqwJ-4p2bA: undetectable	3rqwF-4p2bA: 18.26 3rqwJ-4p2bA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3THR_C_C2FC1410_0 (GLYCINE N-METHYLTRANSFERASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	3 / 3	ARG A 355 PRO A 549 PHE A 541	SO4 A 602 (-2.6A) None None	0.85A	3thrC-4p2bA: undetectable	3thrC-4p2bA: 17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOD_A_HQEA1173_1 (FMN-BINDING PROTEIN)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	TYR A 225 ASP A 80 HIS A 57 HIS A 229	None	1.47A	3zodA-4p2bA: undetectable	3zodA-4p2bA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZS_A_SAMA1475_1 (METHYLTRANSFERASE WBDD)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	3 / 3	ARG A 414 ASP A 401 GLN A 359	None	0.92A	4azsA-4p2bA: undetectable	4azsA-4p2bA: 23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BQF_B_QPSB951_1 (ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 8	ARG A 390 ARG A 355 GLU A 524 GLU A 391	None SO4 A 602 (-2.6A) None None	1.01A	4bqfB-4p2bA: undetectable	4bqfB-4p2bA: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_A_LDPA501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	PHE A 541 ALA A 357 ALA A 481 PRO A 567	None	0.98A	4dtzA-4p2bA: undetectable	4dtzA-4p2bA: 20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	PHE A 541 ALA A 357 ALA A 481 PRO A 567	None	0.98A	4dtzB-4p2bA: undetectable	4dtzB-4p2bA: 20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_C_377C401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.73A	4twdB-4p2bA: undetectable 4twdC-4p2bA: undetectable	4twdB-4p2bA: 17.79 4twdC-4p2bA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_C_377C402_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 5	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.77A	4twdC-4p2bA: undetectable 4twdD-4p2bA: undetectable	4twdC-4p2bA: 17.79 4twdD-4p2bA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_E_377E401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.69A	4twdD-4p2bA: undetectable 4twdE-4p2bA: undetectable	4twdD-4p2bA: 17.79 4twdE-4p2bA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_H_377H401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.68A	4twdG-4p2bA: undetectable 4twdH-4p2bA: undetectable	4twdG-4p2bA: 17.79 4twdH-4p2bA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_J_377J401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	ASN A 368 GLU A 374 TYR A 428 PHE A 394	None	0.69A	4twdI-4p2bA: undetectable 4twdJ-4p2bA: undetectable	4twdI-4p2bA: 17.79 4twdJ-4p2bA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSY_B_ACRB601_2 (4-ALPHA-GLUCANOTRANS FERASE DPE1, CHLOROPLASTIC/AMYLOP LASTIC)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 5	TYR A 91 PHE A 45 LEU A 306 PRO A 47	None	1.14A	5csyB-4p2bA: 2.6	5csyB-4p2bA: 23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_A_ACRA1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.23A	5x7pA-4p2bA: 2.1	5x7pA-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_B_ACRB1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.24A	5x7pB-4p2bA: undetectable	5x7pB-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7Q_A_ACRA1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.22A	5x7qA-4p2bA: undetectable	5x7qA-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7Q_B_ACRB1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.23A	5x7qB-4p2bA: 2.2	5x7qB-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7R_A_ACRA1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.23A	5x7rA-4p2bA: undetectable	5x7rA-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7R_B_ACRB1481_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 6	SER A 114 HIS A 212 GLU A 88 TYR A 112	None	1.22A	5x7rB-4p2bA: undetectable	5x7rB-4p2bA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZVG_A_SAMA401_0 (389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	ALA A 228 ASP A 81 ALA A 113 PRO A 223 PHE A 117	None	1.21A	5zvgA-4p2bA: undetectable	5zvgA-4p2bA: 22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZVG_B_SAMB401_0 (389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	5 / 12	ALA A 228 ASP A 81 ALA A 113 PRO A 223 PHE A 117	None	1.21A	5zvgB-4p2bA: undetectable	5zvgB-4p2bA: 22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_P_CHDP302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4p2b	GLUTAMINE AMINOACYL-TRNA SYNTHETASE (Toxoplasma gondii)	4 / 7	ASP A 226 TYR A 227 TRP A 219 HIS A 212	None	1.35A	6nmpN-4p2bA: undetectable 6nmpP-4p2bA: undetectable	6nmpN-4p2bA: 20.13 6nmpP-4p2bA: 19.10

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CD2_A_FOLA307_0","DIHYDROFOLATE REDUCTASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"ILE A  42;ALA A  68;PRO A  47;PHE A  79;ILE A 238","None","0.87A","1cd2A-4p2bA:undetectable","1cd2A-4p2bA:16.61"],["1P7R_A_NCTA440_1","CYTOCHROME P450-CAM","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"THR A 367;VAL A 433;VAL A 364;ILE A 366","None","0.98A","1p7rA-4p2bA:undetectable","1p7rA-4p2bA:20.92"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.38A","1v54N-4p2bA:undetectable;1v54P-4p2bA:undetectable","1v54N-4p2bA:20.13;1v54P-4p2bA:19.10"],["1V55_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.40A","1v55A-4p2bA:undetectable;1v55C-4p2bA:undetectable","1v55A-4p2bA:20.13;1v55C-4p2bA:19.10"],["2CD2_A_FOLA307_0","DIHYDROFOLATE REDUCTASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"ILE A  42;ALA A  68;PRO A  47;PHE A  79;ILE A 238","None","0.85A","2cd2A-4p2bA:undetectable","2cd2A-4p2bA:16.61"],["2DYR_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.38A","2dyrN-4p2bA:undetectable;2dyrP-4p2bA:undetectable","2dyrN-4p2bA:20.13;2dyrP-4p2bA:19.10"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.41A","2dysA-4p2bA:undetectable;2dysC-4p2bA:undetectable","2dysA-4p2bA:20.13;2dysC-4p2bA:19.10"],["2EGV_A_SAMA1300_0","UPF0088 PROTEIN AQ_165","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"LEU A 309;VAL A 314;GLY A 313;LEU A 303;THR A 572","None","0.99A","2egvA-4p2bA:2.2","2egvA-4p2bA:18.60"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.41A","2eijA-4p2bA:undetectable;2eijC-4p2bA:undetectable","2eijA-4p2bA:20.13;2eijC-4p2bA:19.10"],["2EIJ_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.39A","2eijN-4p2bA:undetectable;2eijP-4p2bA:undetectable","2eijN-4p2bA:20.13;2eijP-4p2bA:19.10"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.40A","2eikA-4p2bA:undetectable;2eikC-4p2bA:undetectable","2eikA-4p2bA:20.13;2eikC-4p2bA:19.10"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.36A","2eikN-4p2bA:undetectable;2eikP-4p2bA:undetectable","2eikN-4p2bA:20.13;2eikP-4p2bA:19.10"],["2EIL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.42A","2eilA-4p2bA:undetectable;2eilC-4p2bA:undetectable","2eilA-4p2bA:20.13;2eilC-4p2bA:19.10"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.39A","2eilN-4p2bA:undetectable;2eilP-4p2bA:undetectable","2eilN-4p2bA:20.13;2eilP-4p2bA:19.10"],["2EIM_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.36A","2eimA-4p2bA:undetectable;2eimC-4p2bA:undetectable","2eimA-4p2bA:20.13;2eimC-4p2bA:19.10"],["2EIM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.45A","2eimN-4p2bA:undetectable;2eimP-4p2bA:undetectable","2eimN-4p2bA:20.13;2eimP-4p2bA:19.10"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.42A","2einA-4p2bA:undetectable;2einC-4p2bA:undetectable","2einA-4p2bA:20.13;2einC-4p2bA:19.10"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.38A","2einN-4p2bA:undetectable;2einP-4p2bA:undetectable","2einN-4p2bA:20.13;2einP-4p2bA:19.10"],["2OIP_A_MTXA605_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"VAL A 339;LEU A 319;PHE A 322;THR A 279;LEU A 274","None","1.01A","2oipA-4p2bA:undetectable","2oipA-4p2bA:21.72"],["2OIP_C_MTXC613_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"VAL A 339;LEU A 319;PHE A 322;THR A 279;LEU A 274","None","1.04A","2oipC-4p2bA:undetectable","2oipC-4p2bA:21.72"],["2ZXW_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.41A","2zxwA-4p2bA:undetectable;2zxwC-4p2bA:undetectable","2zxwA-4p2bA:20.13;2zxwC-4p2bA:19.10"],["2ZXW_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.38A","2zxwN-4p2bA:undetectable;2zxwP-4p2bA:undetectable","2zxwN-4p2bA:20.13;2zxwP-4p2bA:19.10"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.43A","3abkA-4p2bA:undetectable;3abkC-4p2bA:undetectable","3abkA-4p2bA:20.13;3abkC-4p2bA:19.10"],["3AG1_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.41A","3ag1A-4p2bA:undetectable;3ag1C-4p2bA:undetectable","3ag1A-4p2bA:20.13;3ag1C-4p2bA:19.10"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.40A","3ag2A-4p2bA:undetectable;3ag2C-4p2bA:undetectable","3ag2A-4p2bA:20.13;3ag2C-4p2bA:19.10"],["3FL9_D_TOPD200_1","DIHYDROFOLATE REDUCTASE (DHFR)","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"ALA A  58;LEU A 306;ILE A  95;LEU A  77;PHE A  45","None","1.45A","3fl9D-4p2bA:undetectable","3fl9D-4p2bA:13.04"],["3KP6_B_SALB3004_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ILE A  95;PHE A  79;ASP A  80;GLU A  48","None","0.98A","3kp6A-4p2bA:undetectable;3kp6B-4p2bA:undetectable","3kp6A-4p2bA:14.34;3kp6B-4p2bA:14.34"],["3OGP_A_017A200_2","FIV PROTEASE;FIV PROTEASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"LEU A 309;ALA A  58;GLY A 103;VAL A 314;LEU A 319","None","1.31A","3ogpB-4p2bA:undetectable","3ogpB-4p2bA:12.13"],["3R9T_A_BEZA264_0","ECHA1_1","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ALA A 481;ILE A 483;ALA A 527;ALA A 528","None","0.57A","3r9tA-4p2bA:undetectable","3r9tA-4p2bA:19.00"],["3RQW_C_ACHC323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.77A","3rqwC-4p2bA:undetectable;3rqwD-4p2bA:undetectable","3rqwC-4p2bA:18.26;3rqwD-4p2bA:18.26"],["3RQW_I_ACHI323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.75A","3rqwI-4p2bA:undetectable;3rqwJ-4p2bA:undetectable","3rqwI-4p2bA:18.26;3rqwJ-4p2bA:18.26"],["3RQW_J_ACHJ323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"GLU A 374;TYR A 428;PHE A 394;ASN A 368","None","0.74A","3rqwF-4p2bA:undetectable;3rqwJ-4p2bA:undetectable","3rqwF-4p2bA:18.26;3rqwJ-4p2bA:18.26"],["3THR_C_C2FC1410_0","GLYCINE N-METHYLTRANSFERASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",3,"ARG A 355;PRO A 549;PHE A 541","SO4 A 602 (-2.6A);None;None","0.85A","3thrC-4p2bA:undetectable","3thrC-4p2bA:17.88"],["3ZOD_A_HQEA1173_1","FMN-BINDING PROTEIN","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"TYR A 225;ASP A  80;HIS A  57;HIS A 229","None","1.47A","3zodA-4p2bA:undetectable","3zodA-4p2bA:16.58"],["4AZS_A_SAMA1475_1","METHYLTRANSFERASE WBDD","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",3,"ARG A 414;ASP A 401;GLN A 359","None","0.92A","4azsA-4p2bA:undetectable","4azsA-4p2bA:23.06"],["4BQF_B_QPSB951_1","ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ARG A 390;ARG A 355;GLU A 524;GLU A 391","None;SO4 A 602 (-2.6A);None;None","1.01A","4bqfB-4p2bA:undetectable","4bqfB-4p2bA:22.36"],["4DTZ_A_LDPA501_1","CYTOCHROME P450 BM3 VARIANT 8C8","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"PHE A 541;ALA A 357;ALA A 481;PRO A 567","None","0.98A","4dtzA-4p2bA:undetectable","4dtzA-4p2bA:20.30"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"PHE A 541;ALA A 357;ALA A 481;PRO A 567","None","0.98A","4dtzB-4p2bA:undetectable","4dtzB-4p2bA:20.30"],["4TWD_C_377C401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.73A","4twdB-4p2bA:undetectable;4twdC-4p2bA:undetectable","4twdB-4p2bA:17.79;4twdC-4p2bA:17.79"],["4TWD_C_377C402_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.77A","4twdC-4p2bA:undetectable;4twdD-4p2bA:undetectable","4twdC-4p2bA:17.79;4twdD-4p2bA:17.79"],["4TWD_E_377E401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.69A","4twdD-4p2bA:undetectable;4twdE-4p2bA:undetectable","4twdD-4p2bA:17.79;4twdE-4p2bA:17.79"],["4TWD_H_377H401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.68A","4twdG-4p2bA:undetectable;4twdH-4p2bA:undetectable","4twdG-4p2bA:17.79;4twdH-4p2bA:17.79"],["4TWD_J_377J401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASN A 368;GLU A 374;TYR A 428;PHE A 394","None","0.69A","4twdI-4p2bA:undetectable;4twdJ-4p2bA:undetectable","4twdI-4p2bA:17.79;4twdJ-4p2bA:17.79"],["5CSY_B_ACRB601_2","4-ALPHA-GLUCANOTRANSFERASE DPE1, CHLOROPLASTIC\/AMYLOPLASTIC","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"TYR A  91;PHE A  45;LEU A 306;PRO A  47","None","1.14A","5csyB-4p2bA:2.6","5csyB-4p2bA:23.10"],["5X7P_A_ACRA1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.23A","5x7pA-4p2bA:2.1","5x7pA-4p2bA:18.98"],["5X7P_B_ACRB1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.24A","5x7pB-4p2bA:undetectable","5x7pB-4p2bA:18.98"],["5X7Q_A_ACRA1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.22A","5x7qA-4p2bA:undetectable","5x7qA-4p2bA:18.98"],["5X7Q_B_ACRB1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.23A","5x7qB-4p2bA:2.2","5x7qB-4p2bA:18.98"],["5X7R_A_ACRA1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.23A","5x7rA-4p2bA:undetectable","5x7rA-4p2bA:18.98"],["5X7R_B_ACRB1481_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"SER A 114;HIS A 212;GLU A  88;TYR A 112","None","1.22A","5x7rB-4p2bA:undetectable","5x7rB-4p2bA:18.98"],["5ZVG_A_SAMA401_0","389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"ALA A 228;ASP A  81;ALA A 113;PRO A 223;PHE A 117","None","1.21A","5zvgA-4p2bA:undetectable","5zvgA-4p2bA:22.07"],["5ZVG_B_SAMB401_0","389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",5,"ALA A 228;ASP A  81;ALA A 113;PRO A 223;PHE A 117","None","1.21A","5zvgB-4p2bA:undetectable","5zvgB-4p2bA:22.07"],["6NMP_P_CHDP302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4p2b","GLUTAMINE AMINOACYL-TRNA SYNTHETASE","Toxoplasma gondii",4,"ASP A 226;TYR A 227;TRP A 219;HIS A 212","None","1.35A","6nmpN-4p2bA:undetectable;6nmpP-4p2bA:undetectable","6nmpN-4p2bA:20.13;6nmpP-4p2bA:19.10"]]